Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States

BACKGROUND: Prevalence of hemolytic neonatal hyperbilirubinemia (NHB) is not well characterized, and economic burden at the population level is poorly understood. This study evaluated the prevalence, clinical characteristics, and economic burden of hemolytic NHB newborns receiving treatment in U.S....

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Tzy-Chyi, Nguyen, Chi, Ruiz, Nancy, Zhou, Siting, Zhang, Xian, Böing, Elaine A., Tan, Hiangkiat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369553/
https://www.ncbi.nlm.nih.gov/pubmed/30744649
http://dx.doi.org/10.1186/s12887-019-1414-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369553/
https://www.ncbi.nlm.nih.gov/pubmed/30744649
http://dx.doi.org/10.1186/s12887-019-1414-x

Ejemplares similares